Vanguard Fiduciary Trust
JUNS

Vanguard Fiduciary Trust’s Jupiter Neurosciences JUNS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Sell
1,122
-49
-4% -$1.16K ﹤0.01% 4008
2026
Q1 		$33K Buy
+1,171
New +$54K ﹤0.01% 3889

Other funds holding JUNS

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return

Vanguard Fiduciary Trust's JUNS Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Jupiter Neurosciences (JUNS) stake by 4.2% in Q2 2026, selling an estimated $1.16K and leaving 1,122 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4008.

Vanguard Fiduciary Trust first reported a position in JUNS in Q1 2026 and has held it in 2 quarters since. The position peaked at $33K in Q1 2026. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,122 shares of Jupiter Neurosciences worth $18K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 49 Jupiter Neurosciences shares in Q2 2026, an estimated $1.16K.
  • Jupiter Neurosciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4008 holding.
  • Vanguard Fiduciary Trust first reported a position in Jupiter Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Jupiter Neurosciences position peaked at $33K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.